Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
96 studies found for:    Menstruation Disturbances: Clinical Trials
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Conditions: Premenstrual Syndrome;   Menstruation Disturbances
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
2 Recruiting Proof Of Concept Menstrual Hygiene Product-Wondaleaf®
Condition: Other Menstruation Disorders
Intervention: Device: Wondaleaf®
3 Completed a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
Condition: Premenstrual Syndrome
Interventions: Drug: extracts of Vitex agnus castus tablets;   Drug: Placebo
4 Completed Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy
Conditions: Menorrhagia;   Pelvic Pain;   Hysterectomy
Intervention: Procedure: Hysterectomy
5 Completed Randomized Controlled Trial of Acupuncture for Dysmenorrhea
Condition: Dysmenorrhea
Interventions: Procedure: acupuncture;   Procedure: usual care
6 Terminated Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Conditions: Premenstrual Syndrome;   Mastodynia
Interventions: Drug: 20mg VAC BNO 1095 FCT;   Drug: Placebo
7 Not yet recruiting Efficacy Study of Acupuncture in the Prevention of Primary Dysmenorrhea
Condition: Primary Dysmenorrhea
Interventions: Device: Verum acupuncture;   Device: Sham acupuncture;   Behavioral: Usual care
8 Completed Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)
Conditions: Menorrhagia;   Uterine Bleeding
Interventions: Procedure: hysterectomy;   Procedure: endometrial ablation
9 Completed Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
Condition: Heavy Menstrual Bleeding
Interventions: Drug: Levosert-20;   Drug: Mirena
10 Completed Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
Conditions: Menorrhagia;   Leiomyoma;   Uterine Neoplasms
Interventions: Procedure: uterine artery embolization;   Procedure: hysterectomy
11 Terminated A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Condition: Secondary Amenorrhea
Intervention: Drug: Progesterone
12 Completed Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Metformin;   Drug: Placebo
13 Unknown  Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
Condition: Dysmenorrhea
Interventions: Drug: Sanjie analgesic capsule;   Drug: placebo
14 Completed An RCT of Metformin Vs Orlistat in Obese Anovulatory Women
Conditions: Anovulation;   Obesity
Intervention: Drug: Orlistat Vs Metformin
15 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
16 Completed Trial of Homeopathy on Management of Menorrhagia
Condition: Menorrhagia
Interventions: Drug: Homeopathy;   Drug: placebo
17 Completed Treatment of Primary Menstrual Pain With Kanion Capsule
Condition: Primary Dysmenorrhea
Intervention: Drug: Kanion Capsule
18 Completed A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Condition: Amenorrhea
Interventions: Drug: DR-2021a;   Drug: DR-2021b;   Drug: DR-2021c;   Drug: DR-2021d;   Drug: DR-2021e;   Other: Placebo
19 Recruiting Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
Condition: Menorrhagia, Dysmenorrhea
Intervention: Drug: Mirena (Levonorgestrel IUS, BAY86-5028)
20 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years